Assignee
CAI ZELING
US·11 granted patents·28 citations·filing 2007–2011
Top patents by PatentIndex Score
11 records- 0190US8084256B2Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic diseaseCAI ZELING·Filed 2010·Granted Dec 27, 2011·10 cites·1 claims
- 0288US8124408B2Preparation of inactivated artificial antigen presenting cells and their use in cell therapiesCAI ZELING·Filed 2007·Granted Feb 28, 2012·15 cites·24 claims
- 0379US8232101B2Identification of antigenic peptides from multiple myeloma cellsCAI ZELING·Filed 2011·Granted Jul 31, 2012·2 cites·7 claims
- 0473US8075895B2Identification of antigenic peptides from multiple myeloma cellsCAI ZELING·Filed 2009·Granted Dec 13, 2011·1 cites·3 claims
- 0560US8323655B2Identification of antigenic peptides from multiple myeloma cellsCAI ZELING·Filed 2011·Granted Dec 4, 2012·0 cites·3 claims
- 0659US8323965B2Identification of antigenic peptides from multiple myeloma cellsCAI ZELING·Filed 2011·Granted Dec 4, 2012·0 cites·1 claims
- 0759US8133728B2Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic diseaseCAI ZELING·Filed 2010·Granted Mar 13, 2012·0 cites·1 claims
- 0859US8133726B2Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic diseaseCAI ZELING·Filed 2010·Granted Mar 13, 2012·0 cites·1 claims
- 0959US8133972B2IgE antigenic peptidesCAI ZELING·Filed 2010·Granted Mar 13, 2012·0 cites·1 claims
- 1059US8084253B2Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic diseaseCAI ZELING·Filed 2010·Granted Dec 27, 2011·0 cites·1 claims
- 1158US8106153B2Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic diseaseCAI ZELING·Filed 2010·Granted Jan 31, 2012·0 cites·1 claims
Join the waitlist — get patent alerts
Get an alert when CAI ZELING files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →